4 recruiting, 1 enrolling by invitation, 1 withdrawn. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Recruiting 1, Withdrawn 1 |
Follow Pulmonary Embolism Acute Massive: new trials by email Literature Review of Pulmonary Embolism Acute Massive trials Research Report on Pulmonary Embolism Acute Massive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multimodal Physiologic State Intelligence Study OMNIPHYS Multimodal Ultrasound Imaging System - Heart Failure, Cardiomyopathies | Enrolling by invitation | Truway Health, Inc. | 25000 | 2026-09-02 | 2026-09-10 | |
| Non-Invasive Measurement of Cardiac Output and Stroke Volume in PE Non-invasive hemodynamic measurements - Pulmonary Embolism, Pulmonary Embolus/Emboli | Not applicable | Withdrawn | University of California, Los Angeles | 2025-07-15 | 2026-03-18 | |
| Post-registration Trial of the Non-immunogenic Staphylokinase in Massive Pulmonary Embolism Non-immunogenic staphylokinasenon-immunogenic staphylokinase 15 mg as a single intravenous bolus Other Names: Fortelyzin® - Pulmonary Embolism Acute Massive | Recruiting | Supergene, LLC | 20000 | 2025-06-01 | 2026-07-06 | |
| Early Catheter-directed Treatment of High Risk Pulmonary Embolism Early Catheter-Interventional Treatment, Conventional care - Pulmonary Embolism Acute Massive | Not applicable | Recruiting | Leipzig Heart Science gGmbH | 210 | 2024-12-27 | 2026-03-04 |
| Cohort Study on Treatment Comes of Catheter-based Therapy in Patients With Acute Pulmonary Embolism in Hong Kong catheter-based therapy - Pulmonary Embolism Acute, Pulmonary Embolism Acute Massive | Recruiting | Chinese University of Hong Kong | 1000 | 2022-06-01 | 2025-06-19 | |
| Registry of Catheter Intervention in Pulmonary Embolism Pulmonary Embolism, Pulmonary Embolism Acute Massive | Recruiting | Hospital San Carlos, Madrid | 300 | 2018-09-18 | 2026-10-06 |
Pulmonary Embolism (5) · Thrombosis (2) · Acute Kidney Injury (1) · Aortic Diseases (1) · Cardiomyopathies (1) · Clinical Deterioration (1) · Disease (1) · Embolism (1) · Focal cortical dysplasia of Taylor (1) · Heart Failure (1) · Heart Valve Diseases (1) · Hypertension (1) · Hypertension, Pulmonary (1) · Intracranial Aneurysm (1) · Lung Diseases (1)
Cardiovascular Diseases (5) · Embolism and Thrombosis (5) · Respiratory Tract Diseases (5) · Vascular Diseases (5) · Embolism (4) · Lung Diseases (4) · Aneurysm (1) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Atherosclerosis (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Disease Attributes (1) · Disease Progression (1)
Chinese University of Hong Kong (1) · Hospital San Carlos, Madrid (1) · Leipzig Heart Science gGmbH (1) · Supergene, LLC (1) · Truway Health, Inc. (1) · University of California, Los Angeles (1)
United States (2) · Germany (1) · Hong Kong (1) · Russia (1) · Spain (1)
Gavin C Solomon, M.D. (1) · Holger Thiele, MD. Prof. (1) · Karl Fengler, MD, Assoc. Prof. (1) · Richard N Channick, M.D. (1) · Sergey N. Tereschenko, MD, Prof. (1) · Sergey S. Markin, MD, Prof. (1)
PMID 16432055, PMID 20696966, PMID 22494827, PMID 24917641, PMID 26791063, PMID 26961819, PMID 29070502, PMID 32243942, PMID 36801109, PMID 37354942, PMID 39454884, PMID 40391253